Capricor Therapeutics (CAPR) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.53
-0.41
-0.28
-0.16

Details

Expected EPS
-0.316667
Actual EPS
-0.53
Surprise EPS
-0.21
Surprise Percent
+67.37%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.53 per share for Q2 2025.

0 Comments

Share your thoughts